Evidence map›Paper›PMID 30953774›Full record

ArticleBrain, behavior, and immunity2019

Pyridostigmine bromide and stress interact to impact immune function, cholinergic neurochemistry and behavior in a rat model of Gulf War Illness.

V A Macht, J L Woodruff, E S Maissy, C A Grillo, M A Wilson, J R Fadel, L P Reagan

Abstract read
In one paragraph

Article in Brain, behavior, and immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

V A MachtUniversity of South Carolina School of Medicine, Department of Pharmacology, Physiology, & Neuroscience, Columbia, SC, United States; University of South Carolina, Department of Psychology, Columbia, SC, United States; Wm. Jennings Bryant Dorn VA Medical Center, Columbia, SC, United States. Electronic address: vmacht@email.unc.edu.
J L WoodruffUniversity of South Carolina School of Medicine, Department of Pharmacology, Physiology, & Neuroscience, Columbia, SC, United States; Wm. Jennings Bryant Dorn VA Medical Center, Columbia, SC, United States.
E S MaissyUniversity of South Carolina School of Medicine, Department of Pharmacology, Physiology, & Neuroscience, Columbia, SC, United States.
C A GrilloUniversity of South Carolina School of Medicine, Department of Pharmacology, Physiology, & Neuroscience, Columbia, SC, United States; Wm. Jennings Bryant Dorn VA Medical Center, Columbia, SC, United States.
M A WilsonUniversity of South Carolina School of Medicine, Department of Pharmacology, Physiology, & Neuroscience, Columbia, SC, United States; University of South Carolina, Department of Psychology, Columbia, SC, United States; Wm. Jennings Bryant Dorn VA Medical Center, Columbia, SC, United States.
J R FadelUniversity of South Carolina School of Medicine, Department of Pharmacology, Physiology, & Neuroscience, Columbia, SC, United States.
L P ReaganUniversity of South Carolina School of Medicine, Department of Pharmacology, Physiology, & Neuroscience, Columbia, SC, United States; Wm. Jennings Bryant Dorn VA Medical Center, Columbia, SC, United States. Electronic address: lawrence.reagan@uscmed.sc.edu.
University of South Carolina · USWm. Jennings Bryan Dorn VA Medical Center · US

Funding

Hypocretin/orexin modulation of cognitive correlates of brain agingR01AG050518 · NIA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI JIM R FADEL · 2015 to 2026
$2.1M
Hypocretin/orexin modulation of cognitive correlates of brain agingRF1AG050518 · NIA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI FADEL, JIM R · 2022 to 2022
$1.1M
Neural Basis of Individual Differences in Fear ExtinctionI01BX001374 · VA · VETERANS HEALTH ADMINISTRATION · PI Marlene A. Wilson · 2013 to 2026
–
Decreased CNS leptin activity in co-morbid depression and obesityI01BX001804 · VA · VETERANS HEALTH ADMINISTRATION · PI REAGAN, LAWRENCE P · 2013 to 2021
–
Immune basis for hippocampal cholinerginc deficits in pyridostigmine-treated ratsI01BX002664 · VA · VETERANS HEALTH ADMINISTRATION · PI LAWRENCE P REAGAN · 2015 to 2026
–
BLRD VA I01 BX001374BLRD VA I01 BX001804BLRD VA I01 BX002664NIA NIH HHS R01 AG050518NIA NIH HHS RF1 AG050518
6 · The paper itself

Abstract

Gulf War Illness (GWI) is characterized by a constellation of symptoms that includes cognitive dysfunction. While the causes for GWI remain unknown, prophylactic use of the acetylcholinesterase inhibitor pyridostigmine bromide (PB) in combination with the stress of deployment has been proposed to be among the causes of the cognitive dysfunction in GWI. Mechanistically, clinical studies suggest that altered immune function may be an underlying factor in the neurochemical and neurobehavioral complications of GWI. Accordingly, the goal of this study was to determine how responses to an immune challenge (lipopolysaccharide; LPS) or stress impacts inflammation, acetylcholine (ACh) neurochemistry and behavior in an experimental model of GWI. Rats with a history of PB treatment exhibited potentiated increases in C-reactive protein levels in response to a submaximal LPS challenge compared to control rats, indicating that prior treatment with this cholinesterase inhibitor leads to exacerbated inflammatory responses to a subsequent immune challenge. ACh responses to LPS administration were decreased in the hippocampus, but not prefrontal cortex (PFC), in rats with a prior history of PB treatment or stress exposure. Additionally, ACh release in response to acute immobilization stress was attenuated in the PFC and hippocampus in these groups. These attenuated cholinergic responses were accompanied by impairments in contextual and cue-based fear learning. The results of this study suggest that stress and LPS challenges adversely affect central ACh neurochemistry in a rodent model of GWI and support the hypothesis that dysregulated immune responses are mechanistically linked to the neurological complications of GWI.

Indexed as

AcetylcholineAnimalsBehavior, AnimalCholinesterase InhibitorsConditioning, ClassicalC-Reactive ProteinDisease Models, AnimalFearHippocampusInflammationLipopolysaccharidesMalePersian Gulf SyndromePrefrontal CortexPyridostigmine BromideRats, Sprague-DawleyAcetylcholineCholinesterase InhibitorsC-Reactive ProteinLipopolysaccharidesPyridostigmine BromideAcetylcholineC-reactive proteinCue-based fear learningCytokineHippocampusIn vivo microdialysisLipopolysaccharidePrefrontal cortex

Identifiers

PMID30953774
PMCPMC6790976
OpenAlexW2931800643

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.